Comparative efficacy and safety of methylphenidate and atomoxetine for attention-deficit hyperactivity disorder in children and adolescents: Meta-analysis based on head-to-head trials

A Randomized Controlled Trial of an Integrated Brain, Body, and Social Intervention for Children With ADHD

(2016) Stephanie D. Smith et al.   Journal of Attention Disorders

Osmotic Release Oral System Methylphenidate Versus Atomoxetine for the Treatment of Attention-Deficit/Hyperactivity Disorder in Chinese Youth: 8-Week Comparative Efficacy and 1-Year Follow-Up

(2016) Yi Su et al.   JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY

A network meta-analysis of atomoxetine and osmotic release oral system methylphenidate in the treatment of attention-deficit/hyperactivity disorder in adult patients

(2016) Chris Bushe et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Prevalence and incidence of attention-deficit/hyperactivity disorder in Slovenian children and adolescents: a database study from a national perspective

(2015) Matej Štuhec et al.   CROATIAN MEDICAL JOURNAL

Predicting Methylphenidate Response in ADHD Using Machine Learning Approaches

(2015) Jae-Won Kim et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Comparative efficacy and acceptability of atomoxetine, lisdexamfetamine, bupropion and methylphenidate in treatment of attention deficit hyperactivity disorder in children and adolescents: A meta-analysis with focus on bupropion

(2015) Matej Stuhec et al.   JOURNAL OF AFFECTIVE DISORDERS

An Open-Label, Randomized Trial of Methylphenidate and Atomoxetine Treatment in Children with Attention-Deficit/Hyperactivity Disorder

(2015) Chi-Yung Shang et al.   JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY

Annual Research Review: A meta-analysis of the worldwide prevalence of mental disorders in children and adolescents

(2015) Guilherme V. Polanczyk et al.   JOURNAL OF CHILD PSYCHOLOGY AND PSYCHIATRY

Atomoxetine Versus Oros Methylphenidate in Attention Deficit Hyperactivity Disorder: A Six-Month Follow Up Study for Efficacy and Adverse Effects

(2015) Fatih Hilmi ÇETİN et al.   Turkiye Klinikleri Tip Bilimleri Dergisi

Attention-Deficit/Hyperactivity Disorder with Inadequate Response to Stimulants: Approaches to Management

(2014) Ann C. Childress et al.   CNS DRUGS

Systematic evidence synthesis of treatments for ADHD in children and adolescents: indirect treatment comparisons of lisdexamfetamine with methylphenidate and atomoxetine

(2014) N. S. Roskell et al.   CURRENT MEDICAL RESEARCH AND OPINION

Comparative short term efficacy and tolerability of methylphenidate and atomoxetine in attention deficit hyperactivity disorder

(2014) Jasmin Garg et al.   INDIAN PEDIATRICS

Evidence-based guidelines for the pharmacological management of attention deficit hyperactivity disorder: Update on recommendations from the British Association for Psychopharmacology

(2014) Blanca Bolea-Alamañac et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Atomoxetine-induced life-threatening long QT syndrome

(2013) M. Štuhec et al.   IRISH JOURNAL OF MEDICAL SCIENCE

Practitioner Review: Current best practice in the management of adverse events during treatment with ADHD medications in children and adolescents

(2013) Samuele Cortese et al.   JOURNAL OF CHILD PSYCHOLOGY AND PSYCHIATRY

Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis

(2013) Stefan Leucht et al.   LANCET

Suicide related events and attention deficit hyperactivity disorder treatments in children and adolescents: a meta-analysis of atomoxetine and methylphenidate comparator clinical trials

(2013) Chris J Bushe et al.   Child and Adolescent Psychiatry and Mental Health

Common and Unique Therapeutic Mechanisms of Stimulant and Nonstimulant Treatments for Attention-Deficit/Hyperactivity Disorder

(2012) Kurt P. Schulz et al.   ARCHIVES OF GENERAL PSYCHIATRY

Comparative efficacy and acceptability of methylphenidate and atomoxetine in treatment of attention deficit hyperactivity disorder in children and adolescents: a meta-analysis

(2011) Raveen Hanwella et al.   BMC Psychiatry

Comparative study of OROS-MPH and atomoxetine on executive function improvement in ADHD: a randomized controlled trial

(2011) Li Yang et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

ADHD: Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents

(2011)   PEDIATRICS

Differential effects of methylphenidate and atomoxetine on attentional processes in children with ADHD: An event-related potential study using the Attention Network Test

(2011) Oliver Kratz et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

Core ADHD Symptom Improvement With Atomoxetine Versus Methylphenidate

(2010) Philip L. Hazell et al.   Journal of Attention Disorders

Efficacy and Safety Limitations of Attention-Deficit Hyperactivity Disorder Pharmacotherapy in Children and Adults

(2009) Sharon B. Wigal   CNS DRUGS

Atomoxetine and Osmotically Released Methylphenidate for the Treatment of Attention Deficit Hyperactivity Disorder: Acute Comparison and Differential Response

(2008) Jeffrey H. Newcorn et al.   AMERICAN JOURNAL OF PSYCHIATRY